Filing Details
- Accession Number:
- 0001415889-18-000047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-12 16:56:43
- Reporting Period:
- 2018-01-10
- Accepted Time:
- 2018-01-12 16:56:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1386570 | Chromadex Corp. | CDXC | Medicinal Chemicals & Botanical Products (2833) | 262940963 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437237 | Jr L Frank Jaksch | 10005 Muirlands Blvd. Suite G Irvine CA 92618 | Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-10 | 22,130 | $4.50 | 223,687 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-10 | 22,130 | $6.52 | 201,557 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-11 | 6,249 | $4.50 | 207,806 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-11 | 6,249 | $6.50 | 201,557 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2018-01-10 | 22,130 | $0.00 | 22,130 | $4.50 |
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2018-01-11 | 6,249 | $0.00 | 6,249 | $4.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 202,804 | 2009-04-21 | 2018-04-21 | No | 4 | M | Direct |
| 196,555 | 2009-04-21 | 2018-04-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,075,052 | Indirect | By Black Sheep, FLP |
Footnotes
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on November 17, 2017. The options exercised and sold were scheduled to expire on April 21, 2018 and Mr. Jaksch sold the shares so that the proceeds can be used to cover the exercise payment and applicable withholding taxes due.
- The weighted average sale price for the transaction reported was $6.52, and the range of prices were between $6.50 and $6.58. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Billionaire Hedge Funds
